Loss-of-Function Variants in CUL3 Cause a Syndromic Neurodevelopmental Disorder.
Journal
Annals of neurology
ISSN: 1531-8249
Titre abrégé: Ann Neurol
Pays: United States
ID NLM: 7707449
Informations de publication
Date de publication:
20 Sep 2024
20 Sep 2024
Historique:
revised:
27
08
2024
received:
16
11
2023
accepted:
27
08
2024
medline:
20
9
2024
pubmed:
20
9
2024
entrez:
20
9
2024
Statut:
aheadofprint
Résumé
De novo variants in cullin-3 ubiquitin ligase (CUL3) have been strongly associated with neurodevelopmental disorders (NDDs), but no large case series have been reported so far. Here, we aimed to collect sporadic cases carrying rare variants in CUL3, describe the genotype-phenotype correlation, and investigate the underlying pathogenic mechanism. Genetic data and detailed clinical records were collected via multicenter collaboration. Dysmorphic facial features were analyzed using GestaltMatcher. Variant effects on CUL3 protein stability were assessed using patient-derived T-cells. We assembled a cohort of 37 individuals with heterozygous CUL3 variants presenting a syndromic NDD characterized by intellectual disability with or without autistic features. Of these, 35 have loss-of-function (LoF) and 2 have missense variants. CUL3 LoF variants in patients may affect protein stability leading to perturbations in protein homeostasis, as evidenced by decreased ubiquitin-protein conjugates in vitro. Notably, we show that 4E-BP1 (EIF4EBP1), a prominent substrate of CUL3, fails to be targeted for proteasomal degradation in patient-derived cells. Our study further refines the clinical and mutational spectrum of CUL3-associated NDDs, expands the spectrum of cullin RING E3 ligase-associated neuropsychiatric disorders, and suggests haploinsufficiency via LoF variants is the predominant pathogenic mechanism. ANN NEUROL 2024.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 American Neurological Association.
Références
Sarikas A, Hartmann T, Pan Z‐Q. The cullin protein family. Genome Biol 2011;12:220.
Baek K, Scott DC, Schulman BA. NEDD8 and ubiquitin ligation by cullin‐RING E3 ligases. Curr Opin Struc Biol 2021;67:101–109.
Zou Y, Liu Q, Chen B, et al. Mutation in CUL4B, which encodes a member of Cullin‐RING ubiquitin ligase complex, causes X‐linked mental retardation. Am J Hum Genetics 2007;80:561–566.
Tarpey PS, Raymond FL, O'Meara S, et al. Mutations in CUL4B, which encodes a ubiquitin E3 ligase subunit, cause an X‐linked mental retardation syndrome associated with aggressive outbursts, seizures, relative macrocephaly, central obesity, hypogonadism, pes Cavus, and tremor. Am J Hum Genetics 2007;80:345–352.
Huber C, Dias‐Santagata D, Glaser A, et al. Identification of mutations in CUL7 in 3‐M syndrome. Nat Genet 2005;37:1119–1124.
Boyden LM, Choi M, Choate KA, et al. Mutations in kelch‐like 3 and cullin 3 cause hypertension and electrolyte abnormalities. Nature 2012;482:98–102.
Nakashima M, Kato M, Matsukura M, et al. De novo variants in CUL3 are associated with global developmental delays with or without infantile spasms. J Hum Genet 2020;65:727–734.
Kato K, Miya F, Oka Y, et al. A novel missense variant in CUL3 shows altered binding ability to BTB‐adaptor proteins leading to diverse phenotypes of CUL3‐related disorders. J Hum Genet 2021;66:491–498.
Iwafuchi S, Kikuchi A, Endo W, et al. A novel stop‐gain CUL3 mutation in a Japanese patient with autism spectrum disorder. Brain Dev 2020;43:303–307.
Vincent KM, Bourque DK. A novel splice site CUL3 variant in a patient with neurodevelopmental delay. Brain Dev 2023;45:244–249.
Zaidi S, Choi M, Wakimoto H, et al. De novo mutations in histone‐modifying genes in congenital heart disease. Nature 2013;498:220–223.
Kong A, Frigge ML, Masson G, et al. Rate of de novo mutations and the importance of father's age to disease risk. Nature 2012;488:471–475.
O'Roak BJ, Vives L, Girirajan S, et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 2012;485:246–250.
Wang T, Guo H, Xiong B, et al. De novo genic mutations among a Chinese autism spectrum disorder cohort. Nat Commun 2016;7:13316.
Study TD, Autism HMC. For, consortium U, et al. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 2014;515:209–215.
Kosmicki JA, Samocha KE, Howrigan DP, et al. Refining the role of de novo protein‐truncating variants in neurodevelopmental disorders by using population reference samples. Nat Genet 2017;49:504–510.
Lin GN, Corominas R, Lemmens I, et al. Spatiotemporal 16p11.2 protein network implicates cortical late mid‐fetal brain development and KCTD13‐Cul3‐RhoA pathway in psychiatric diseases. Neuron 2015;85:742–754.
Dong Z, Chen W, Chen C, et al. CUL3 deficiency causes social deficits and anxiety‐like behaviors by impairing excitation‐inhibition balance through the promotion of cap‐dependent translation. Neuron 2019;105:475–490.e6.
Morandell J, Schwarz LA, Basilico B, et al. Cul3 regulates cytoskeleton protein homeostasis and cell migration during a critical window of brain development. Nat Commun 2021;12:3058.
Sobreira N, Schiettecatte F, Valle D, Hamosh A. GeneMatcher: a matching tool for connecting investigators with an interest in the same gene. Hum Mutat 2015;36:928–930.
Firth HV, Richards SM, Bevan AP, et al. DECIPHER: database of chromosomal imbalance and phenotype in humans using Ensembl resources. Am J Hum Genetics 2009;84:524–533.
Kaplanis J, Samocha KE, Wiel L, et al. Evidence for 28 genetic disorders discovered by combining healthcare and research data. Nature 2020;586:757–762.
Satterstrom FK, Kosmicki JA, Wang J, et al. Large‐scale exome sequencing Study implicates both developmental and functional changes in the neurobiology of autism. Cell 2020;180:568–584.e23.
Wang T, Hoekzema K, Vecchio D, et al. Large‐scale targeted sequencing identifies risk genes for neurodevelopmental disorders. Nat Commun 2020;11:4932.
Hsieh T‐C, Bar‐Haim A, Moosa S, et al. GestaltMatcher facilitates rare disease matching using facial phenotype descriptors. Nat Genet 2022;54:349–357.
Hustinx A, Hellmann F, Sumer O, et al. Improving deep facial phenotyping for ultra‐rare disorder verification using model ensembles. IEEE/CVF Winter Conference on Applications of Computer Vision (WACV) (IEEE, 2023), 2023. doi:10.1109/wacv56688.2023.00499
Gurovich Y, Hanani Y, Bar O, et al. Identifying facial phenotypes of genetic disorders using deep learning. Nat Med 2019;25:60–64.
Lesmann H, Lyon GJ, Caro P, et al. GestaltMatcher Database—A global reference for facial phenotypic variability in rare human diseases [Internet]. medRxiv, 2024. Available from. https://www.medrxiv.org/content/10.1101/2023.06.06.23290887v3.
Fonteneau J‐F, Larsson M, Somersan S, et al. Generation of high quantities of viral and tumor‐specific human CD4+ and CD8+ T‐cell clones using peptide pulsed mature dendritic cells. J Immunol Methods 2001;258:111–126.
Rice GI, Melki I, Frémond M‐L, et al. Assessment of type I interferon signaling in pediatric inflammatory disease. J Clin Immunol 2017;37:123–132.
Feliciano P, Zhou X, Astrovskaya I, et al. Exome sequencing of 457 autism families recruited online provides evidence for autism risk genes. Npj Genom Med 2019;4:19.
Yuen RKC, Merico D, Bookman M, et al. Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder. Nat Neurosci 2017;20:602–611.
Consortium TS, Feliciano P, Daniels AM, et al. SPARK: a US cohort of 50,000 families to accelerate autism research. Neuron 2018;97:488–493.
Coe BP, Stessman HAF, Sulovari A, et al. Neurodevelopmental disease genes implicated by de novo mutation and copy number variation morbidity. Nat Genet 2019;51:106–116.
Ware JS, Samocha KE, Homsy J, Daly MJ. Interpreting de novo variation in human disease using denovolyzeR. Curr Protoc Hum Genetics 2015;87:7.25.1–7.25.15.
Karczewski KJ, Francioli LC, Tiao G, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 2020;581:434–443.
Drivas TG, Li D, Nair D, et al. A second cohort of CHD3 patients expands the molecular mechanisms known to cause Snijders Blok‐Campeau syndrome. Eur J Hum Genet 2020;28:1422–1431.
Sáez MA, Fernández‐Rodríguez J, Moutinho C, et al. Mutations in JMJD1C are involved in Rett syndrome and intellectual disability. Genet Med 2016;18:378–385.
Slavotinek A, Hagen JM v, Kalsner L, et al. Jumonji domain containing 1C (JMJD1C) sequence variants in seven patients with autism spectrum disorder, intellectual disability and seizures. Eur J Med Genet 2020;63:103850.
Sarasua SM, Dwivedi A, Boccuto L, et al. 22q13.2q13.32 genomic regions associated with severity of speech delay, developmental delay, and physical features in Phelan–McDermid syndrome. Genet Med 2014;16:318–328.
Lumaka A, Cosemans N, Mampasi AL, et al. Facial dysmorphism is influenced by ethnic background of the patient and of the evaluator. Clin Genet 2017;92:166–171.
Pantel JT, Zhao M, Mensah MA, et al. Advances in computer‐assisted syndrome recognition by the example of inborn errors of metabolism. J Inherit Metab Dis 2018;41:533–539.
Jin SC, Homsy J, Zaidi S, et al. Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands. Nat Genet 2017;49:1593–1601.
Jerabkova K, Sumara I. Cullin 3, a cellular scripter of the non‐proteolytic ubiquitin code. Semin Cell Dev Biol 2018;93:100–110.
Davidge B, Rebola KG d O, Agbor LN, et al. Cul3 regulates cyclin E1 protein abundance via a degron located within the N‐terminal region of cyclin E. J Cell Sci 2019;132:jcs233049.
Yanagiya A, Suyama E, Adachi H, et al. Translational homeostasis via the mRNA cap‐binding protein, eIF4E. Mol Cell 2012;46:847–858.
Arima K, Kinoshita A, Mishima H, et al. Proteasome assembly defect due to a proteasome subunit beta type 8 (PSMB8) mutation causes the autoinflammatory disorder, Nakajo‐Nishimura syndrome. Proc National Acad Sci U S A 2011;108:14914–14919.
Kitamura A, Maekawa Y, Uehara H, et al. A mutation in the immunoproteasome subunit PSMB8 causes autoinflammation and lipodystrophy in humans. J Clin Invest 2011;121:4150–4160.
Liu Y, Ramot Y, Torrelo A, et al. Mutations in proteasome subunit β type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity. Arthritis Rheum 2012;64:895–907.
Brehm A, Liu Y, Sheikh A, et al. Additive loss‐of‐function proteasome subunit mutations in CANDLE/PRAAS patients promote type I IFN production. J Clin Invest 2015;125:4196–4211.
Poli MC, Ebstein F, Nicholas SK, et al. Heterozygous truncating variants in POMP escape nonsense‐mediated decay and cause a unique immune dysregulatory syndrome. Am J Hum Genetics 2018;102:1126–1142.
de Jesus AA, Brehm A, VanTries R, et al. Novel proteasome assembly chaperone mutations in PSMG2/PAC2, cause the autoinflammatory interferonopathy, CANDLE/PRAAS4. J Allergy Clin Immun 2019;143:1939–1943.e8.
Sarrabay G, Méchin D, Salhi A, et al. PSMB10, the last immunoproteasome gene missing for PRAAS. J Allergy Clin Immun 2019;145:1015–1017.e6.
Pilaz L‐J, Patti D, Marcy G, et al. Forced G1‐phase reduction alters mode of division, neuron number, and laminar phenotype in the cerebral cortex. Proc National Acad Sci 2009;106:21924–21929.